Company Filing History:
Years Active: 2024
Title: Harini Kandadi: Innovator in Gene Expression Markers
Introduction
Harini Kandadi is a notable inventor based in East Windsor, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the area of gene expression markers. Her work focuses on improving patient outcomes in cancer treatment.
Latest Patents
Harini Kandadi holds 1 patent for her invention titled "Gene expression markers for predicting overall survival in subjects treated with sipuleucel-T." This patent involves gene expression profiling in patients with metastatic castration-resistant prostate cancer (mCRPC). The method includes determining gene expression levels of specific biomarkers and transforming these levels into a score that predicts overall survival in response to treatment with sipuleucel-T.
Career Highlights
Kandadi is currently employed at Dendreon Pharmaceuticals LLC, where she continues to advance her research in cancer therapies. Her innovative approach to gene expression profiling has the potential to enhance treatment strategies for patients.
Collaborations
Harini collaborates with various professionals in her field, including her coworker James B Trager. Their combined expertise contributes to the development of effective cancer treatment methodologies.
Conclusion
Harini Kandadi's work in gene expression markers represents a significant advancement in cancer treatment research. Her contributions are paving the way for improved patient care and outcomes in oncology.